$177 Million is the total value of Ghost Tree Capital, LLC's 51 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 106.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XBI | New | SPDR SERIES TRUSTput | $11,037,000 | – | 220,000 | +100.0% | 6.24% | – |
| ACAD | New | ACADIA PHARMACEUTICALS INCput | $9,786,000 | – | 350,000 | +100.0% | 5.54% | – |
| CELG | New | CELGENE CORP | $9,028,000 | – | 90,202 | +100.0% | 5.11% | – |
| EW | New | EDWARDS LIFESCIENCES CORPcall | $8,821,000 | – | 100,000 | +100.0% | 4.99% | – |
| BSX | New | BOSTON SCIENTIFIC CORP | $8,465,000 | – | 450,000 | +100.0% | 4.79% | – |
| IWM | New | ISHARES TRput | $8,297,000 | – | 75,000 | +100.0% | 4.70% | – |
| HZNP | New | HORIZON PHARMA PLC | $7,042,000 | – | 425,000 | +100.0% | 3.98% | – |
| PACB | Sell | PACIFIC BIOSCIENCES CALIF IN | $5,950,000 | -39.6% | 700,000 | -6.7% | 3.37% | -16.5% |
| ABBV | New | ABBVIE INCcall | $5,712,000 | – | 100,000 | +100.0% | 3.23% | – |
| AGIO | New | AGIOS PHARMACEUTICALS INC | $5,684,000 | – | 140,000 | +100.0% | 3.22% | – |
| ALXN | New | ALEXION PHARMACEUTICALS INC | $5,569,000 | – | 40,000 | +100.0% | 3.15% | – |
| TEVA | New | TEVA PHARMACEUTICAL INDS LTDcall | $5,351,000 | – | 100,000 | +100.0% | 3.03% | – |
| MRTX | MIRATI THERAPEUTICS INC | $5,350,000 | -32.3% | 250,000 | 0.0% | 3.03% | -6.4% | |
| SAGE | Sell | SAGE THERAPEUTICS INC | $5,130,000 | -56.0% | 160,000 | -20.0% | 2.90% | -39.2% |
| SPNC | Sell | SPECTRANETICS CORP | $5,082,000 | -22.4% | 350,000 | -19.5% | 2.88% | +7.2% |
| OPHT | New | OPHTHOTECH CORP | $5,072,000 | – | 120,000 | +100.0% | 2.87% | – |
| IHF | New | ISHARES TRus hlthcr pr etf | $4,818,000 | – | 39,500 | +100.0% | 2.73% | – |
| NVRO | Sell | NEVRO CORP | $4,220,000 | -26.5% | 75,000 | -11.8% | 2.39% | +1.7% |
| NSTG | Sell | NANOSTRING TECHNOLOGIES INC | $3,425,000 | -41.8% | 225,000 | -43.8% | 1.94% | -19.6% |
| NUVA | Sell | NUVASIVE INC | $3,406,000 | -72.6% | 70,000 | -69.6% | 1.93% | -62.2% |
| IART | Sell | INTEGRA LIFESCIENCES HLDGS C | $3,368,000 | -58.6% | 50,000 | -58.3% | 1.91% | -42.8% |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $3,299,000 | – | 40,000 | +100.0% | 1.87% | – |
| IHI | New | ISHARES TRu.s. med dvc etf | $3,062,000 | – | 25,000 | +100.0% | 1.73% | – |
| RMD | New | RESMED INC | $2,891,000 | – | 50,000 | +100.0% | 1.64% | – |
| VRX | New | VALEANT PHARMACEUTICALS INTLcall | $2,630,000 | – | 100,000 | +100.0% | 1.49% | – |
| DBVT | Sell | DBV TECHNOLOGIES S Asponsored adr | $2,583,000 | -51.4% | 45,000 | -43.8% | 1.46% | -32.8% |
| ACAD | Sell | ACADIA PHARMACEUTICALS INC | $2,097,000 | -76.5% | 75,000 | -70.0% | 1.19% | -67.5% |
| WMGI | Sell | WRIGHT MED GROUP N V | $2,075,000 | -82.8% | 125,000 | -75.0% | 1.17% | -76.3% |
| PTLA | New | PORTOLA PHARMACEUTICALS INCcall | $2,040,000 | – | 100,000 | +100.0% | 1.15% | – |
| STJ | New | ST JUDE MED INC | $2,008,000 | – | 36,500 | +100.0% | 1.14% | – |
| VRTX | New | VERTEX PHARMACEUTICALS INC | $2,007,000 | – | 25,253 | +100.0% | 1.14% | – |
| ENTL | Sell | ENTELLUS MED INC | $2,001,000 | -20.9% | 110,000 | -26.7% | 1.13% | +9.4% |
| MDT | New | MEDTRONIC PLC | $1,993,000 | – | 26,578 | +100.0% | 1.13% | – |
| ACHN | Sell | ACHILLION PHARMACEUTICALS IN | $1,930,000 | -70.2% | 250,000 | -58.3% | 1.09% | -58.8% |
| VCYT | Sell | VERACYTE INC | $1,845,000 | -26.8% | 341,708 | -2.4% | 1.04% | +1.2% |
| CYNA | Sell | CYNAPSUS THERAPEUTICS INC | $1,803,000 | -22.2% | 151,535 | -0.1% | 1.02% | +7.5% |
| GNMK | Sell | GENMARK DIAGNOSTICS INC | $1,581,000 | -50.3% | 300,000 | -26.8% | 0.90% | -31.3% |
| IHE | New | ISHARES TRu.s. pharma etf | $1,342,000 | – | 9,800 | +100.0% | 0.76% | – |
| TNDM | Sell | TANDEM DIABETES CARE INC | $1,307,000 | -68.4% | 150,000 | -57.1% | 0.74% | -56.3% |
| LBIO | New | LION BIOTECHNOLOGIES INC | $1,270,000 | – | 250,000 | +100.0% | 0.72% | – |
| ADHD | Sell | ALCOBRA LTD | $1,137,000 | -63.8% | 300,000 | -40.0% | 0.64% | -50.0% |
| PTLA | Sell | PORTOLA PHARMACEUTICALS INC | $816,000 | -93.1% | 40,000 | -82.6% | 0.46% | -90.5% |
| CHMA | New | CHIASMA INC | $687,000 | – | 75,000 | +100.0% | 0.39% | – |
| ENDP | New | ENDO INTL PLC | $678,000 | – | 24,100 | +100.0% | 0.38% | – |
| VTAE | Sell | VITAE PHARMACEUTICALS INC | $671,000 | -86.5% | 101,188 | -63.2% | 0.38% | -81.4% |
| AKTX | Sell | AKARI THERAPEUTICS PLCsponsored adr | $653,000 | -4.4% | 46,622 | -1.0% | 0.37% | +32.1% |
| HRTX | New | HERON THERAPEUTICS INC | $475,000 | – | 25,000 | +100.0% | 0.27% | – |
| ADAP | Sell | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $407,000 | -83.9% | 50,000 | -76.2% | 0.23% | -77.8% |
| CLVS | New | CLOVIS ONCOLOGY INC | $355,000 | – | 18,500 | +100.0% | 0.20% | – |
| SBBP | STRONGBRIDGE BIOPHARMA PLC | $332,000 | -40.0% | 72,726 | 0.0% | 0.19% | -16.8% | |
| OCRX | Sell | OCERA THERAPEUTICS INC | $132,000 | -66.2% | 45,000 | -64.0% | 0.08% | -53.1% |
| CPRX | Exit | CATALYST PHARMACEUTICALS INC | $0 | – | -376,000 | -100.0% | -0.38% | – |
| FOLD | Exit | AMICUS THERAPEUTICS INCcall | $0 | – | -100,000 | -100.0% | -0.40% | – |
| RGNX | Exit | REGENXBIO INC | $0 | – | -60,000 | -100.0% | -0.41% | – |
| CORI | Exit | CORIUM INTL INC | $0 | – | -125,000 | -100.0% | -0.42% | – |
| DVAX | Exit | DYNAVAX TECHNOLOGIES CORP | $0 | – | -55,000 | -100.0% | -0.54% | – |
| FLDM | Exit | FLUIDIGM CORP DEL | $0 | – | -150,000 | -100.0% | -0.66% | – |
| CLVS | Exit | CLOVIS ONCOLOGY INCcall | $0 | – | -50,000 | -100.0% | -0.72% | – |
| PCRX | Exit | PACIRA PHARMACEUTICALS INC | $0 | – | -30,000 | -100.0% | -0.94% | – |
| TNXP | Exit | TONIX PHARMACEUTICALS HLDG C | $0 | – | -350,000 | -100.0% | -1.10% | – |
| SGYPQ | Exit | SYNERGY PHARMACEUTICALS DEL | $0 | – | -600,000 | -100.0% | -1.39% | – |
| RTRX | Exit | RETROPHIN INC | $0 | – | -200,000 | -100.0% | -1.58% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -1.58% | – |
| FPRX | Exit | FIVE PRIME THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -1.70% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -45,000 | -100.0% | -1.73% | – |
| ACOR | Exit | ACORDA THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -1.75% | – |
| INCY | Exit | INCYTE CORP | $0 | – | -50,000 | -100.0% | -2.22% | – |
| PRTA | Exit | PROTHENA CORP PLC | $0 | – | -90,000 | -100.0% | -2.51% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -25,000 | -100.0% | -3.14% | – |
| BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -120,000 | -100.0% | -3.16% | – |
| ZLTQ | Exit | ZELTIQ AESTHETICS INC | $0 | – | -275,000 | -100.0% | -3.21% | – |
| MNKKQ | Exit | MALLINCKRODT PUB LTD CO | $0 | – | -135,000 | -100.0% | -4.12% | – |
| SGEN | Exit | SEATTLE GENETICS INC | $0 | – | -225,000 | -100.0% | -4.14% | – |
| AMGN | Exit | AMGEN INC | $0 | – | -75,000 | -100.0% | -4.98% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2016-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 30 | Q3 2023 | 7.3% |
| ASCENDIS PHARMA A/S - ADR | 28 | Q3 2023 | 11.8% |
| BIOCRYST PHARMACEUTICALS INC | 25 | Q2 2023 | 2.4% |
| AMICUS THERAPEUTICS INC | 23 | Q3 2023 | 5.6% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2023 | 9.1% |
| SPDR SER TR | 20 | Q3 2022 | 16.9% |
| IOVANCE BIOTHERAPEUTICS INC | 18 | Q2 2023 | 5.5% |
| ROCKET PHARMACEUTICALS INC | 18 | Q2 2023 | 6.1% |
| SAGE THERAPEUTICS INC | 18 | Q1 2021 | 4.8% |
| IMMUNOMEDICS INC | 17 | Q2 2020 | 8.7% |
View Ghost Tree Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-16 |
| 13F-HR | 2021-11-15 |
View Ghost Tree Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.